when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Obesity · news · pharmadog

← back to Obesity

News mentioning Obesity

367 stories

May 12, 266 takeaways from STAT’s investigation into the U.S. alcohol epidemicstat

May 11, 26STAT+: Pharmalittle: We’re reading about Medicare and Alzheimer’s drugs, estrogen patch shortages, and morestat

May 8, 26STAT+: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drugstat

May 8, 26Lilly to invest extra $4.5B across Indiana manufacturingbiopharma dive

May 8, 26STAT+: Up and down the ladder: The latest comings and goingsstat

May 8, 26STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and morestat

May 7, 26Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papersstat

May 7, 26Key takeaways from WHO briefing on hantavirus cruise ship outbreakstat

May 7, 26Seaport’s IPO adventure, obesity pill battles, and Makary’s troublesstat

May 7, 26Science is becoming less disruptive. Is an aging workforce to blame?stat

May 7, 26STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and morestat

May 6, 26Novo hikes guidance on Wegovy pill’s fast sales startbiopharma dive

May 6, 26STAT+: How a global effort to explore the ‘dark proteome’ is upending our understanding of human diseasestat

May 6, 26GSK goes to China for $1B siRNA deal in Arrowhead's obesity laneendpoints

May 6, 26STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share pricestat

May 6, 26STAT+: Pharmalittle: We’re reading about a PhRMA ad campaign aimed at 340B, sales of Novo’s obesity pill, and morestat

May 6, 26Novo Nordisk's Q1 in four words: Pills, pricing, payments and pressureendpoints

May 6, 26STAT+: OpenAI wants to ‘have their cake and eat it too’ with health AI policy recommendationsstat

May 5, 26STAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricingstat

May 5, 26The Type of Fat—Not the Amount—Fuels Pancreatic Canceronclive

May 5, 26Pfizer ends Trillium-related development as R&D spend jumpsendpoints

May 5, 26STAT+: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and morestat

May 4, 26STAT+: French regulator fines Novo and Lilly over weight loss ad campaignsstat

May 4, 26STAT+: Pump the brakes on AI, buddy; and deposition deadlockstat

May 4, 26STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more newsstat

May 4, 26STAT+: Biotech raises $42 million to run Huntington’s disease trialstat

May 4, 26Opinion: Are blue zones real? Answering that question is harder than everstat

May 2, 26Federal appeals court blocks mailing of abortion pill mifepristonestat

May 2, 26Opinion: What do medical students think about their education?stat

May 1, 26Amgen launches late-stage obesity trial in patients who switch from rival drugsendpoints

← prevpage 11 of 13next →